The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 25 Sep 2007
doi: 10.1242/jcs.005751
Research Article
The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway
María Llamazares,
Alvaro J. Obaya,
Angela Moncada-Pazos,
Ritva Heljasvaara,
Jesús Espada,
Carlos López-Otín,
and
Santiago Cal*
* Author for correspondence (e-mail: santical{at}uniovi.es)
Members of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family of proteolytic enzymes are implicated in a variety of physiological processes, such as collagen maturation, organogenesis, angiogenesis, reproduction and inflammation. Moreover, deficiency or overexpression of certain ADAMTS proteins is directly involved in serious human diseases, including cancer. However, the functional roles of other family members, such as ADAMTS12, remain unknown. Here, by using different in vitro and in vivo approaches, we have evaluated the possible role of ADAMTS12 in the development and progression of cancer. First, we show that expression of ADAMTS12 in Madin-Darby canine kidney (MDCK) cells prevents the tumorigenic effects of hepatocyte growth factor (HGF) by blocking the activation of the Ras-MAPK signalling pathway and that this regulation involves the thrombospondin domains of the metalloproteinase. We also show that addition of recombinant human ADAMTS12 to bovine aortic endothelial cells (BAE-1 cells) abolishes their ability to form tubules upon stimulation with vascular endothelial growth factor (VEGF). Additionally, tumours induced in immunodeficient SCID mice injected with A549 cells overexpressing ADAMTS12 show a remarkable growth deficiency in comparison with tumours formed in animals injected with parental A549 cells. Overall, our data suggest that ADAMTS12 confers tumour-protective functions upon cells that produce this proteolytic enzyme.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
A. Moncada-Pazos, A. J. Obaya, M. F. Fraga, C. G. Viloria, G. Capella, M. Gausachs, M. Esteller, C. Lopez-Otin, and S. Cal
The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer
J. Cell Sci.,
August 15, 2009;
122(16):
2906 - 2913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-H. Bai, D.-W. Wang, L. Kong, Y. Zhang, Y. Luan, T. Kobayashi, H. M. Kronenberg, X.-P. Yu, and C.-j. Liu
ADAMTS-7, a Direct Target of PTHrP, Adversely Regulates Endochondral Bone Growth by Associating with and Inactivating GEP Growth Factor
Mol. Cell. Biol.,
August 1, 2009;
29(15):
4201 - 4219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Viloria, A. J. Obaya, A. Moncada-Pazos, M. Llamazares, A. Astudillo, G. Capella, S. Cal, and C. Lopez-Otin
Genetic Inactivation of ADAMTS15 Metalloprotease in Human Colorectal Cancer
Cancer Res.,
June 1, 2009;
69(11):
4926 - 4934.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Rocks, G. Paulissen, F. Quesada-Calvo, C. Munaut, M.-L. A. Gonzalez, M. Gueders, J. Hacha, C. Gilles, J.-M. Foidart, A. Noel, et al.
ADAMTS-1 Metalloproteinase Promotes Tumor Development through the Induction of a Stromal Reaction In vivo
Cancer Res.,
November 15, 2008;
68(22):
9541 - 9550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gutierrez-Fernandez, A. Fueyo, A. R. Folgueras, C. Garabaya, C. J. Pennington, S. Pilgrim, D. R. Edwards, D. L. Holliday, J. L. Jones, P. N. Span, et al.
Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion
Cancer Res.,
April 15, 2008;
68(8):
2755 - 2763.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2007
